Complement proteins c3 and c4 bind to collagen and elastin in the vascular wall: A potential role in vascular stiffness and atherosclerosis

Clinical and Translational Science

Volumn 4, Issue 3, 2011, Pages 146-152

  Shields, Kelly J ^a   Stolz, Donna ^b   Watkins, Simon C ^b   Ahearn, Joseph M ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c ALLEGHENY HEALTH NETWORK   (United States)

Author keywords

Aorta; Atherosclerosis; Immunohistochemistry; Immunology; Inflammation; Vasculature

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ELASTIN; PROTEIN; PROTEIN C3; PROTEIN C4; THIOESTER; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADVENTITIA; AORTA ATHEROSCLEROSIS; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; EXTRACELLULAR MATRIX; NONHUMAN; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

ANIMALS; AORTA; AORTA, THORACIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; COLLAGEN; COMPLEMENT C3; COMPLEMENT C4; ELASTIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING;

MUS;

EID: 79959710421     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2011.00304.x     Document Type: Article

References (30)

1. Thalmann S, Meier CA. Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res. 2007; 75(4): 690-701.
2. Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res. 2009; 81(2): 370-380.
3. Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, Weintraub NL. Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol. 10(2):191-196. [Epub Jan 7 2010].
4. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res. 2009; 104(4): 541-549. [Epub Jan 2 2009].
5. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340(2): 115-126.
6. Santelices LC, Calano SJ, Erhart JC, Prantil RL, Haney JL, Vorp DA, Ahearn JM. Experimental system for ex vivo measurement of murine aortic stiffness. Physiol Meas. 2007; 28(8): N39-N49.
7. Dean D, Herbener TE. Cross sectional human anatomy. Philadelphia: Lippincott Williams and Wilkins2000.
8. Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation. Cardiovasc Res. 2007; 75(4): 640-648.
9. Szeplaki G, Prohaszka Z, Duba J, Rugonfalvi-Kiss S, Karadi I, Kokai M, Kramer J, Fust G, Kleiber M, Romics L, et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis. 2004; 177: 383-389.
10. Muscari A, Bozzoli C, Puddu GM, Sangiorgi Z, Dormi A, Rovinetti C, Descovich GC, Puddu P. Association of serum C3 levels with the risk of myocardial infarction. Am J Med. 1995; 98: 357-364.
11. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis. 1989; 9(5): 567-578.
12. Schwartz CJ, Kelley JL, Nerem RM, Sprague EA, Rozek MM, Valente AJ, Edwards EH, Prasad AR, Kerbacher JJ, Logan SA. Pathophysiology of the atherogenic process. Am J Cardiol. 1989; 64(13): 23G-30G.
13. van der Wal AC, Das PK, Bentz van de Berg D, van der Loos CM, Becker AE. Laboratory Investigation. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. 1989; 61(2): 166-170.
14. Laine P, Pentikainen MO, Wurzner R, Penttila A, Paavonen T, Meri S, Kovanen PT. Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction. Am J Cardiol. 2002; 90: 404-408.
15. Law SK, Dodds AW. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci. 1997; 6(2): 263-274.
16. Svensson L, Närlid I, Oldberg A. Fibromodulin and lumican bind to the same region on collagen type I fibrils. FEBS Lett. 2000; 470(2): 178-182.
17. Hedbom E, Heinegård D. Interaction of a 59-kDa connective tissue matrix protein with collagen I and collagen II. J Biol Chem. 1989; 264(12): 6898-6905.
18. Scott JE. Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry. 1996; 35(27): 8795-8799.
19. Ström A, Ahlqvist E, Franzén A, Heinegård D, Hultgårdh-Nilsson A. Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor deficient mice: an immunohistochemical study. Histol Histopathol. 2004; 19(2): 337-347.
20. Peake PW, Shen Y, Walther A, Charlesworth JA. Adiponectin binds C1q and activates the classical pathway of complement. Biochem Biophys Res Commun. 2008; 367(3): 560-565.
21. Peake P, Shen Y. Factor H binds to the N-terminus of adiponectin and modulates complement activation. Biochem Biophys Res Commun. 2010; 397(2): 361-366.
22. van Greevenbroek MM. The expanding role of complement in adipose tissue metabolism and lipoprotein function. Curr Opin Lipidol. 2009; 20(4): 353-354.
23. White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992; 267(13): 9210-9213.
24. Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem. 1992; 267(18): 12736-12741.
25. Choy LN, Spiegelman BM. Regulation of alternative pathway activation and C3a production by adipose cells. Obes Res. 1996; 4(6): 521-532.
26. Zhang J, Wright W, Bernlohr DA, Cushman SW, Chen X. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2007; 292: E1433-E1440.
27. Ruan C-C, Zhu D-L, Chen Q-Z, Chen J, Guo S-J, Li X-D, Gao P-J. Perivascular adipose tissue-derived complement 3 is required for adventitial fibroblast functions and adventitial remodeling in deoxycorticosterone acetate-salt hypertensive rats. Arterioscler Thromb Vasc Biol. 2010; 30: 2568-2574.
28. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009; 78(6): 539-552.
29. Onat A, Can G, Rezvani R, Cianflone K. Complement C3 and cleavage products in cardiometabolic risk. Clinica Chimica Acta. 2011; 412: 1171-1179.
30. Prévost G, Bulckaen H, Gaxatte C, Boulanger E, Béraud G, Creusy C, Puisieux F, Fontaine P. Structural modifications in the arterial wall during physiological aging and as a result of diabetes mellitus in a mouse model: are the changes comparable Diabetes & Metabolism. 2011; 37: 106-111.